Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Depreciation & Amortization (CF) (2022)

CervoMed (CRVO) has disclosed Depreciation & Amortization (CF) for 6 consecutive years, with -$883995.0 as the latest value for Q4 2022.

  • Quarterly Depreciation & Amortization (CF) changed N/A to -$883995.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was -$883995.0 through Sep 2023, down 234.82% year-over-year, with the annual reading at $93416.0 for FY2021, 9.45% down from the prior year.
  • Depreciation & Amortization (CF) hit -$883995.0 in Q4 2022 for CervoMed, down from $655698.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of -$883995.0 in Q4 2022 to a low of -$883995.0 in Q4 2022.